Bladder cancer is a heterogeneous group of tumours with at least 40 histological subgroups.
Patients with localized disease can be cured with surgical resection or radiotherapy, but …

Immunohistochemistry has become an essential ancillary examination for the identification
and classification of carcinomas of unknown primary site (CUPs). Over the last decade, the …

Urachal carcinoma is a rare urological disease. The shortage of data about diagnosis and
surgical treatment in literature makes it hard for clinicians to make a decision. Indeed …

Urachal cancer (UrC) is a rare but aggressive cancer. Due to overlap** histomorphology,
discrimination of urachal from primary bladder adenocarcinomas (PBAC) and …

The urachus is a fibrous remnant of the allantois. After birth, it remains throughout life as the
medial umbilical ligament running from the apex of the bladder to the umbilicus but without …

Abstract Background Urachal cancer (UrC) is a rare disease with limited availability of
representative incidence and clinical data. Although, the prevalence is accounting for less …

Abstract Purpose of Review The aim of this review is to sum up the state of the art of urachal
carcinoma (UC) in order to easily guide clinicians. Recent Findings UC is a rare and …

The urachus is a tubular structure that extends cranially from the anterior dome of the
bladder to the umbilicus. Urachal anomalies (UA) formation results from incomplete …

Urachal cancer (UrC) is a rare but aggressive malignancy often diagnosed in advanced
stages requiring systemic treatment. Although cytotoxic chemotherapy is of limited …

Urachal carcinoma, a rare cancer arising from urachus, accounts for about 1% of bladder
cancer. The diagnosis at stage I shows about 63% 5-year survival whereas only 8% of the …